Maxim Sees High Risk Profile for Akari Therapeutics, plc (AKTX) Amid Capital Needs
TheFly reported on April 8 that Maxim Group downgraded AKTX from Buy to Hold and did not assign a price target.
Akari Therapeutics Plc (AKTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 68,099.15 | $787,226 | 0.01% | |
| 2. | Palo Alto Investors William Leland Edwards | 3,650.6 | $42,201 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.90 | 3,000 | $2,700.00 | 298,574 | 2025-08-25 | Filing | |
| $0.93 | 8,000 | $7,440.00 | 295,574 | 2025-08-22 | Filing | |
| $0.94 | 10,000 | $9,400.00 | 287,574 | 2025-08-21 | Filing | |
| $1.16 | 5,203 | $6,035.48 | 277,574 | 2025-06-24 | Filing | |
| $1.15 | 943 | $1,084.45 | 272,371 | 2025-06-23 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 181 | $932 | 0% | |
| 2. | 7,250 | $877 | 0% | |
| 3. | 5 | $26 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
8 Oversold Biotech Stocks to Invest In Now
On February 5, J.P. Morgan revealed major themes that are expected to affect healthcare in 2026, emphasizing a resurgence of interest in the biopharma sector.
Here's What Is Happening In Financial Markets Today?
“Wall Street stocks on Monday were aiming to start the second quarter with tepid gains.
What Is Going On In The Financial Markets Today?
“U.S. stocks were slightly lower on Friday, dragged down by technology stocks as investors locked in gains of what is likely to be Wall Street's strongest first-quarter performance in four years.
What Do Hedge Funds Think of Akari Therapeutics PLC (ADR) (AKTX)?
The government requires hedge funds and wealthy investors with over a certain portfolio size to file a report that shows their positions at the end of every quarter.
Two Stocks That Have Deerfield Management And Anchor Bolt Capital Excited
In a recent filing with the Securities and Exchange Commission (SEC), James E.
Hedge Fund Resource Center